Skip to main content
SpringerLink
Log in

Indikationen zur Zystektomie und Wahl der Harnableitung — Welche Entscheidungsparameter stehen zur Verfügung?

  • Kontroversen in der Uro-Onkologie
  • Published:
Der Urologe B

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Ahlering TE, Kanellos A, Boyd SD, Lieskovsky G, Skinner DG, Bernstein L (1988) A comparative study of perioperative complications with kock pouch urinary diversion in highly irradiated versus nonirradiated patients. 139: 1202–1207

    CAS  Google Scholar 

  2. Bouffioux C, Kurth KH, Bono A, Oosterlinck W, Boeken Kruger C, De Pauw M, Sylvester R, the members of the European Organization for Research and Treatment of Cancer, Genitourinary Group (1995) Intravesical adjuvant chemotherapy for superficial transitional cell bladder carcinoma: results of 2 European Organization for Research and Treatment of Cancer randomized trials with mitomycin C and doxorubicin comparing early versus delayed instillations and short-term versus long-term treatment. J Urol 153: 934–941

    Article  CAS  PubMed  Google Scholar 

  3. Browman GP, Wong G, Hodson I, Satthya J, Rossell R, McAlpine L, Skingley P, Levine MN (1993) Influence of cigarette smoking on the efficacy of radiation therapy in head and neck cancer. N Engl J Med 321: 159–163

    Article  Google Scholar 

  4. Chyou P-H, Nomura AMY, Stemmermann GN (1992) A prospective study of the attributable risk of cancer due to cigarette smoking. Am J Public Health 82: 37–40

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  5. Gustafson H, Tribukait B (1985) Characterization of bladder carcinomas by flow DNA analysis. Eur Urol 11: 410–417

    CAS  PubMed  Google Scholar 

  6. Hayes RB, Friedell GH, Zahm SH, Cole P (1993) Are the known bladder cancer risk-factors associated with more advanced bladder cancer? Cancer Causes Control 4: 157–162

    Article  CAS  PubMed  Google Scholar 

  7. Herr H, Jakse G (1991) pT1 bladder cancer. Eur Urol 20: 1–8

    CAS  PubMed  Google Scholar 

  8. Hudson MA, Herr HW (1995) Carcinoma in situ of the bladder. J Urol 153, 564–572

    Article  CAS  PubMed  Google Scholar 

  9. Jakse G, Loidl W, Seeber G, Hofstädter F (1987) Stage T1, grade 3 transitional cell carcinoma of the bladder: an unfavourable tumor? J Urol 137: 39–43

    CAS  PubMed  Google Scholar 

  10. Kaubisch S, Lum BL, Reese J, Freiha F, Torti FM (1991) In stage T1 bladder cancer grade is the primary determinant for risk of muscle invasion. J Urol 146: 28–31

    CAS  PubMed  Google Scholar 

  11. Kavoussi LR, Torrence RJ, Gillen DP, Hudson MA, Haaf MO, Dresner SM, Ratliff TL, Catalona WJ (1988) Results of 6 weekly intravesical Bacillus Calmette-Guérin instillations on the treatment of superficial bladder tumors. J Urol 139: 935–940

    CAS  PubMed  Google Scholar 

  12. Klan R, Loy V, Huland H (1991) Residual tumor discovered in routine second transurethral resection in patients with stage T1 transitional cell carcinoma of the bladder. J Urol 146: 316–318

    CAS  PubMed  Google Scholar 

  13. Klän R, Meier Th, Wegner HEH, Miller K (1994) Langzeitbeobachtung des T1G3-Blasenkarzinom: Progreßpotential und therapeutische Konsequenzen. Urologe [A] 33 [Suppl]: 20

  14. Krege S, Goepel M, Meyer-Schwickerath M, Otto T, Rubben H (1996) Gibt es eine individuelle Entscheidung zur Harnableitung? Urologe [A] 35: 291–296

    CAS  Google Scholar 

  15. Kurth KH, Denis L, Bouffioux C, Sylvester R, Debruyne FMJ, Pavone-Macaluso M, Oosterlinck W (1995) Factors affecting recurrence and progression in superficial bladder tumours. Eur J Cancer 31 A: 1840–46

  16. Lamm DL (1992) Long-term results of intravesical therapy for superficial bladder cancer. Urol Clin North Am 19: 573–80

    CAS  PubMed  Google Scholar 

  17. Malkowicz SB, Nichols P, Lieskovsky G, Boyd SD, Huffman J, Skinner DG (1990) The role of radical cystectomy in the management of high grade superficial bladder cancer (PA, P1, PIS and P2). J Urol 144: 641–645

    CAS  PubMed  Google Scholar 

  18. Masters JRW, Camplejohn RS, Parkinson MC, Woodhouse CRI (1985) DNA ploidy and the prognosis of stage pT1 bladder cancer. Br J Urol 64: 403–408

    Article  Google Scholar 

  19. Rübben H, Dahm HH, Lutzeyer W (1981) Rezidivhäufigkeit und Tumorprogression superfizialer Harnblasentumoren. Urologe [A] 20: 211–214

    PubMed  Google Scholar 

  20. RUH (Registryfor Urinary Tract Tumors) (1985) Harnwegstumorregister. Jahresbericht. Verh Dtsch Ges Urol 37: 665

    Google Scholar 

  21. Schmitz-Dräger BJ, Kishima M, Goebell P, Jax TW, Gerharz C-D, Bültel H, Schulz WA, Ebert T, Ackermann R (1997) P53 and mdm2 in the development and progression of bladder cancer. Eur Urol 32: 487–93

    PubMed  Google Scholar 

  22. Smith JA, Whitmore WF Jr (1981) Regional lymph node metastasis from bladder cancer. J Urol 126: 591–595

    PubMed  Google Scholar 

  23. Stein JP, Cote RJ, Freeman JA, Esrig D, Elmajian DA, Groshen S, Skinner EC, Boyd SD, Lieskovsky G, Skinner DG (1995) Indications for lower urinary tract reconstruction in women after cystectomy for bladder cancer: a pathological review of female cystectomy specimens. J Urol 154: 1329–1333

    Article  CAS  PubMed  Google Scholar 

  24. Stöckle M, Alken P, Engelmann U, Jacobi GH, Riedmiller H, Hohenfellner R (1987) Radical cystektomy —often too late? Eur Urol 13: 361–367

    PubMed  Google Scholar 

  25. Trasher JB, Frazier HA, Robertson JE, Paulson DF (1994) Does a stage pT0 cystectomy specimen confer a survival advantage in patients with minimally invasive bladder cancer? J Urol 152: 393–396

    Google Scholar 

  26. Vögeli TA, Holtmann C, Ackermann R (1994) Ergebnisse der Therapie von Blasentumoren im Stadium pT 1. Urologe [A] 33 [Suppl]: 20

    Google Scholar 

  27. Weber A, Köhrmann KU, Hansen S, Alken P (1991) Oberflächliches Harnblasenkarzinom T1G3: Welche Patienten sind Kandidaten für eine Zystektomie? Urologe [A] 30 [Suppl]

Download references

Author information

Authors and Affiliations

  1. Urologische Universitätsklinik, Heinrich-Heine-Universität, Moorenstraße 5, D-40225, Düsseldorf

    B. J. Schmitz-Dräger & F. Jankevicius

Authors
  1. B. J. Schmitz-Dräger
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. F. Jankevicius
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Schmitz-Dräger, B.J., Jankevicius, F. Indikationen zur Zystektomie und Wahl der Harnableitung — Welche Entscheidungsparameter stehen zur Verfügung?. Der Urologe B 38, S49–S52 (1998). https://doi.org/10.1007/s001310050375

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s001310050375

Search

Navigation